supported by grants from Beijing Xisike Clinical Oncology Research Foundation(No.YYoung2023-0114).
Objective:Definitive chemoradiotherapy(dCRT)is the standard treatment for unresectable locally advanced esophageal cancer.However,this treatment is associated with substantial toxicity,and most malnourished or elderly...
financially supported by the Science and Technology Plan Project of Guangzhou (No. 202102010171);National Natural Science Foundation Cultivation Project of the Third Affiliated Hospital of Sun Yat-sen University (No. 2020GZRPYMS11);Natural Science Foundation of Guangdong Province (No. 2018A030313641);Natural Science Foundation of Guangdong Province (No. 2016A030313848);Science and Technology Plan Project of Guangzhou (No. 201704020175)。
Objective: Unresectable hepatocellular carcinoma(uHCC) continues to pose effective treatment options. The objective of this study was to assess the efficacy and safety of combining low-dose cyclophosphamide with lenva...
supported by the Beijing Municipal Administration of Hospitals Incubating Program(No.PX2019039)。
Objective:The aim of this study was to prospectively compare double-tract reconstruction(DTR)and esophagogastrostomy(EG)after proximal gastrectomy(PG)regarding the incidence of reflux esophagitis,quality of life(QOL),...
supportedbyBeijing Municipal Administration of Hospitals(No.DFL20181103);Beijing Hospitals Authority Innovation Studio of Young Staff Funding Support(No.202123).
Objective: To explore the change and feasibility of surgical techniques of laparoscopic transhiatal(TH)-lower mediastinal lymph node dissection(LMLND) for adenocarcinoma of the esophagogastric junction(AEG)according t...
supported by the Chinese Medical Foundation(No.2020064)。
Objective:This study aims to verify the feasibility and efficacy of laparoscopic lower mediastinal lymphadenectomy for Siewert typeⅡ/Ⅲadenocarcinoma of esophagogastric junction(AEG).Setting:An exploratory,observatio...
Objective:Bevacizumab has an important and evolving role in improving outcomes in patients with metastatic colorectal cancer(mCRC)worldwide and was approved in China in 2010.However,there are limited real-world data o...
funded by the Gastric Cancer Diagnose and Treatment Project(D171100006517004,D17110700650000)of Beijing Municipal Science&Technology Commission;supported by Beijing Municipal Administration of Hospital Clinical Medicine Development of Special Funding Support(ZYLX201701)
Objective： Infra-pyloric artery （IPA） is an important anatomical landmark in treatment of gastric cancer and is the key vessel for pylorus-preserving gastrectomy and subgroup of infra-pyloric lymph nodes. However, ...
Objective： Advances in high-throughput genomic profiling and the development of new targeted therapies improve patient＇s survival. In gastrointestinal （GI） malignancies, the concept of personalized medicine （PM）...
supported by grants from the National Natural Science Foundation of China (Grant No. 81472620);Shanghai Science and Technology Planning Fund (No. 13140902100);Shanghai Combination Study Project for Major Diseases (No. 2014ZYJB0101);Shanghai Health and Family Planning Commission (No. JGY1404)
Objective： The aim of this prospective, single-arm phase II trial was to confirm the safety and efficacy of neoadjuvant chemotherapy（NAC） using oxaliplatin plus capecitabine（Cap OX） for patients with operable loc...
supported by the fund of the National Key Basic Research Program "973 project" (2015CB554000);grants from the State Key Project Specialized for Infectious Diseases of China(2008ZX10002015 and 2012ZX10002008-002)
Background： The temporal relationship between hepatitis B virus （HBV） mutations and hepatocellular carcinoma （HCC） remains unclear. Methods： We conducted a meta-analysis including cohort and nested case-control ...
条 记 录，以下是1-10
